Navigation Links
DST HealthCare Launches Medical Drug Management Service™
Date:1/11/2011

KANSAS CITY, Mo., Jan. 11, 2011 /PRNewswire/ -- Clients of Argus Health Systems, Inc. and DST Health Solutions, LLC, now have access to a customizable, rules-based product designed to clinically edit and price medical drug claims. Medical Drug Management Service™ (MDMS) is a new, DST HealthCare-branded solution developed to facilitate effective drug trend management, assist with appropriate and consistent patient care and significantly improve management of medical drug spend. DST HealthCare Holdings, Inc., consists of Argus Health Systems, Inc. and DST Health Solutions.

"Health plans will need to increase their focus on outcomes and compliance in order to operate more efficiently and maintain mandated minimum medical loss ratios," said Jonathan Boehm, president and chief executive officer of DST HealthCare.  

MDMS applies a structured approach to medical pricing administration, data management and compliance editing. MDMS facilitates NDC-level pricing and rebate administration, integrates medical and pharmacy reporting, and produces medical claims that require less time and money to process.

"Health plans must focus on the total cost of medication administered in the medical setting, and support patient-centered intervention, in order to meet these new industry mandates," Boehm said. "The ability to measure results, provide feedback, drive payment for performance, and modify programs will help optimize results and promote quality."

"Medical Drug Management Service supports customizable clinical and pricing rules for drugs with HCPCS (Healthcare Common Procedure Coding System) Level II codes, and automatically identifies appropriate intervention opportunities," said John Aforismo, chief executive officer and founder of RJ Health Systems. RJ Health Systems provides accurate drug intelligence to the healthcare industry through customizable databases, patient education materials, and consulting services.  

DST HealthCare's MDMS solution provides reporting, analytics, trending and modeling of member, provider, drug, prescribing and utilization patterns. MDMS produces detailed clinical edits that promote patient safety and lower healthcare costs.

As wholly-owned subsidiaries of DST Systems, these two companies jointly developed MDMS to help health plans effectively manage specialty drug costs.

About DST HealthCare Holdings, Inc.DST HealthCare is the holding company for Argus Health Systems, Inc. and DST Health Solutions, LLC.

About Argus Health Systems, Inc. Argus is a leading independent provider of healthcare information management services supporting commercial, Medicaid and Medicare Part D with a business model that provides full disclosure and transparency.  Argus serves a wide range of clients and key healthcare organizations, including managed care organizations, pharmacy benefit managers and pharmaceutical manufacturers.

About DST Health Solutions, LLCDST Health Solutions delivers systems and services that help improve efficiency, reduce operational costs, increase speed to market, and facilitate medical cost management and price containment. Our clients include commercial health plans, consumer-directed plans, government plans (Medicare Advantage, Medicare Part D and Medicaid) and physician practices. DST Health Solutions' enterprise applications and outsourcing services include claims processing, member and provider management, benefit plan management, new product development, care management and medical management, and decision support/analytics. DST Health Solutions is a wholly-owned subsidiary of DST Systems, Inc. For more information about DST Health Solutions, call 800-272-4799, e-mail inforequests@dsthealthsolutions.com or visit www.dsthealthsolutions.com.

The information and comments above may include forward-looking statements respecting DST and its businesses. Such information and comments are based on DST's views as of today, and actual actions or results could differ. There could be a number of factors affecting future actions or results, including those set forth in DST's latest periodic financial report (Form 10-K or 10-Q) filed with the Securities and Exchange Commission. All such factors should be considered in evaluating any forward-looking comment. The Company will not update any forward-looking statements in this press release to reflect future events.MEDIA CONTACT:Chris Goldman, Healthcare Media RelationsDST Systems, Inc.DST Media Hotline: 816-843-9087
'/>"/>

SOURCE DST HealthCare Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Siemens Launches PEP, a Personalized Education Plan for Clinical Laboratory and Healthcare Professionals
2. Anadys Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference
3. Ventus Medical to Present at JP Morgan 29th Annual Healthcare Conference
4. UL White Paper Examines Key Implications of Growing Home Healthcare Industry
5. WuXi PharmaTech Provides Update of 2010 Financial Guidance, to Present at J.P. Morgan Healthcare Conference
6. Ardea Biosciences Earns $15 Million Payment from Bayer HealthCare AG for Achievement of Important Clinical Milestone in Ongoing Collaboration
7. Questcor Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2011
8. Perrigo Company to Present at the 29th Annual J.P. Morgan Healthcare Conference
9. Healthpoint to Present at 29th Annual J.P. Morgan Healthcare Conference
10. Amgen to Present at the 29th Annual JP Morgan Healthcare Conference
11. Isis Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, ... therapeutic genome editing, announced that the U.S. Food ... Investigational New Drug (IND) application for SB-318, a ... therapy for Mucopolysaccharidosis Type I (MPS I). The ... Sangamo to initiate a Phase 1/2 clinical study ...
(Date:2/8/2016)... February 8, 2016 ... published by Allied Market Research titled, "World ... Forecasts, 2014-2020", estimates the world synthetic biology market ... and sequencing technology segment would continue to lead ... tools segment, collectively, held around half of the ...
(Date:2/8/2016)... , 8. Februar 2016  LivaNova, ... heute eine Infografik mit dem Titel „Epilepsy ... Welt), mit der der Krankheit gegenüber ein ... dazu ermutigen soll, Medikamentenresistenz bei Epilepsie auf ... allgemeinen Diskussion zu machen. Mithilfe der neuen ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... The Federal Laboratory Consortium ... . The site houses a wealth of federal resources that businesses can leverage ... called technology transfer (T2). As a network of over 300 federal laboratories, the ...
(Date:2/8/2016)... ... February 08, 2016 , ... A man who has struggled to quit smoking, a man ... , was determined to find solutions to his problems – and he did. Now Nabat, ... is ready to introduce his breakthrough inventions to the world and better people's lives. His ...
(Date:2/8/2016)... ... February 08, 2016 , ... The Bell Agency, a full ... beneficiary of their ongoing community enrichment program. The current campaign fundraises for Angels ... are now being accepted at: http://www.angelsanddoves.com/donate.html . , Angels & Doves was ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... frequently. While a significant number of women and men with eating disorders report ... itself, that best predicts the development of an eating disorder. , At ...
(Date:2/8/2016)... ... , ... TopConsumerReviews.com recently awarded their highest five-star rating to a product from ... a cluster of melanin when exposed to sunlight. Although most moles are benign and ... embarrassment. Historically, mole removal has involved a painful, often expensive visit to ...
Breaking Medicine News(10 mins):